Literature DB >> 10823749

A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia.

J Hayashi1, N Furusyo, I Ariyama, Y Sawayama, Y Etoh, S Kashiwagi.   

Abstract

To clarify the mechanism of liver damage induced by hepatitis C virus (HCV) and to determine whether the damage is related to hepatocellular carcinoma (HCC), HCV RNA levels were measured serially, and HCV genome mutations were analyzed from serum of 274 Japanese patients with chronic HCV viremia during 1993-1998. All patients had alanine aminotransferase (ALT) levels measured during 1986-1998. Patients with consistently normal ALT levels had identical and highly conserved HCV core regions; however, those with consistently abnormal ALT levels had quasi species, and the population of the quasi species changed over time. HCV RNA levels did not change in the 274 patients. HCC developed in 31% of 80 patients with consistently abnormal ALT levels and in 4% of 92 patients with intermittently abnormal ALT levels but never in 102 patients with ALT levels consistently normal during 1993-1998. In patients with chronic HCV viremia, persistent liver damage plays an important role in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823749     DOI: 10.1086/315431

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.

Authors:  Alejandro Schijman; Rodney Colina; Sergey Mukomolov; Olga Kalinina; Laura García; Shobha Broor; Ajoy Varma Bhupatiraju; Peter Karayiannis; Baldip Khan; Cristina Mogdasy; Juan Cristina
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.

Authors:  Norihiro Furusyo; Jun Hayashi; Kenichiro Kashiwagi; Hisashi Nakashima; Shigeki Nabeshima; Yasunori Sawayama; Naoko Kinukawa; Seizaburo Kashiwagi
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia.

Authors:  Norihiko Kubo; Norihiro Furusyo; Hisashi Nakashima; Kenichiro Kashiwagi; Jun Hayashi
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

Review 5.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

6.  Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

Authors:  J M Matthews-Greer; G C Caldito; S D Adley; R Willis; A C Mire; R M Jamison; K L McRae; J W King; W L Chang
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

7.  Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.

Authors:  Koji Takayama; Norihiro Furusyo; Eiichi Ogawa; Hiroaki Ikezaki; Motohiro Shimizu; Masayuki Murata; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients.

Authors:  Walaa H Ahmed; Norihiro Furusyo; Saad Zaky; Abeer Sharaf Eldin; Hany Aboalam; Eiichi Ogawa; Masayuki Murata; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  TT-virus infection in Japanese general population and in hemodialysis patients.

Authors:  Yoko Kanamoto-Tanaka; Norihiro Furusyo; Hisashi Nakashima; Yoshitaka Etoh; Seizaburo Kashiwagi; Jun Hayashi
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

10.  Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.

Authors:  Satoshi Ogata; Motoko Nagano-Fujii; Yonson Ku; Seitetsu Yoon; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.